Evidence & regulatory context
- Mechanism
- Recombinant human oncostatin M (OSM) and ciliary neurotrophic factor (CNTF) are gp130-family cytokines; research biologics, no confident ChEMBL match
- Target
- Not recorded
- Injury models
- Crush
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseCrushPeripheral-nerve crushBALB/cn = 40 mice total in optic nerve crush experiments (12 for 4-se…Intravitreal injection via 33-gauge needle3 micrograms in 2 microlitres per eye (OSM or CNTF); contro…Immediately after optic nerve crush, within 1 minute
Model: Unilateral intraorbital optic nerve crush 1-2 mm behind the globe using extra-fine self-closing forceps, for 4 seconds or 1 second; contralateral eye untreated
Two weeks after 4-second crush, OSM-treated eyes retained 42.0, 47.2 and 48.1 per cent of normal retinal ganglion cell density at 0.5, 1.0 and 1.5 mm eccentricity versus 13.7, 14.1 and 14.6 per cent in PBS-treated eyes (two-way ANOVA, effect of treatment P<0.001). After the milder 1-second crush, p…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.